• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Cetuximab (2)

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Label Sections with
Pharmacogenomic
Information
CetuximabOncologyKRASKRAS codon 12 and 13
mutation negative
Indications and Usage
Dosage and Administration
Warnings and Precautions
Adverse Reactions
Clinical Pharmacology
Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling